Case ID
FC-2024-DEMO
Patient Code
PT-DEMO
Female Age
32 yrs
BMI
23
Infertility Duration
18 mo
Risk Stratification
Identified Factors
Primary Factor
Ovulatory Factor
No additional contributing factors identified.
Semen Analysis (WHO 2021)
Reference: ≥16 M/mL
Reference: ≥42%
Reference: ≥4%
Clinical Recommendations
- Ovulation induction with letrozole (first-line for PCOS)
- Timed intercourse or IUI for 3–4 cycles
- Monthly follicular monitoring via transvaginal ultrasound
- HSG to assess tubal patency
- Fasting insulin and glucose (rule out insulin resistance)
- Prenatal vitamins with folic acid 400–800 mcg daily
- Limit alcohol to <5 units/week for both partners
- Stress management: mindfulness, counselling support
Evidence Base & Guidelines
| Source | Year | Recommendation | Strength |
|---|---|---|---|
| ASRM | 2023 | Letrozole preferred over clomiphene for ovulation induction in PCOS | Strong |
| ESHRE | 2023 | Lifestyle modification first-line for overweight anovulatory women | Strong |
| WHO | 2021 | Semen reference values: concentration ≥16M/mL, motility ≥42%, morphology ≥4% | Strong |
Clinical Decision Support Tool — Not a substitute for specialist evaluation.
Algorithm based on WHO 2021, ASRM 2022–2023, ESHRE 2022–2023, NICE 2023, EAU 2023 Guidelines. Always apply clinical judgement.
